Fecal Microbiota Transplantation, a tool to transfer healthy longevity

Ageing Res Rev. 2024 Nov 23:102585. doi: 10.1016/j.arr.2024.102585. Online ahead of print.

Abstract

The complex gut microbiome influences host aging and plays an important role in the manifestation of age-related diseases. Restoring a healthy gut microbiome via Fecal Microbiota Transplantation (FMT) is receiving extensive consideration to therapeutically transfer healthy longevity. Herein, we comprehensively review the benefits of gut microbial rejuvenation - via FMT - to promote healthy aging, with few studies documenting life length properties. This review explores how preconditioning donors via standard - lifestyle and pharmacological - antiaging interventions reshape gut microbiome, with the resulting benefits being also FMT-transferable. Finally, we expose the current clinical uses of FMT in the context of aging therapy and address FMT challenges - regulatory landscape, protocol standardization, and health risks - that require refinement to effectively utilize microbiome interventions in the elderly.

Keywords: FMT-concerns; aging; fecal microbiota transplantation; gut-microbiome; longevity.

Publication types

  • Review